The Trump administration has signed drug-pricing deals with nine pharmaceutical companies, including Sun Pharma, to lower US medicine costs through most-favoured-nation pricing. In exchange, firms receive tariff concessions. Sun Pharma will offer lower prices to Medicaid and on future innovative medicines, supporting Washington’s push.
Business
Sun Pharma, 8 Others Sign US Drug Pricing Deals
